5-Amino-1MQ 50 mg

5-Amino-1MQ is a synthetic small-molecule research compound commonly supplied as 5-amino-1-methylquinolinium iodide.

It is not a peptide. The compound is investigated as an inhibitor of nicotinamide N-methyltransferase, an enzyme involved in nicotinamide handling and cellular methylation pathways.

Controlled experimental research involving 5-Amino-1MQ includes enzyme interactions, nicotinamide metabolism, molecular signaling, and cellular metabolic-pathway models.

Each vial contains 50 mg of 5-Amino-1MQ research material. Batch-specific analytical documentation should be consulted for chemical identity, counterion, purity, and specifications of the applicable tested lot.

For research use only. Not for human or veterinary use, administration, or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

5-Amino-1MQ has been examined in preclinical models involving NNMT inhibition, nicotinamide metabolism, methyl-donor pathways, enzyme activity, and cellular signaling.

Available evidence remains preclinical and does not establish human safety, efficacy, dosing, pharmacokinetics, weight reduction, fat loss, increased energy expenditure, or therapeutic benefit.

This product must not be represented as a fat burner, metabolic booster, weight-loss compound, or treatment for obesity.

References to published literature are provided for scientific context only and do not constitute medical advice or a claim of efficacy.

Packaging

Vials are lyophilized, sealed, and shipped in insulated, temperature-controlled packaging where applicable.

Delivery

In-stock orders are prepared for dispatch on business days. Domestic transit is typically 2–5 business days depending on the service selected at checkout.

Storage on arrival

Store lyophilized at -20°C, protected from light. Store according to the product-specific laboratory storage specifications and applicable analytical documentation.